ITEMS IN AFP WITH KEYWORD:
Inhaled insulin provides an alternative route of administration for rapid-acting insulin but offers no other benefit over available insulin therapy. It may reduce, but not eliminate, the need for self-injection in patients with type 1 diabetes. In patients with type 2 diabetes, the risk of hypoglyce...
Feb 1, 2007 Issue
The Role of Exercise in Patients with Type 2 Diabetes [Cochrane for Clinicians]
Regular exercise reduces A1C levels, adiposity, and triglyceride levels. However, no research has definitively proved a benefit of exercise on patient-oriented outcomes such as diabetes-related morbidity and mortality.
Jan 15, 2007 Issue
CDC Releases Data on Visual Impairment in Patients with Diabetes [Practice Guidelines]
The Centers for Disease Control and Prevention (CDC) has released data on visual impairment in patients with diabetes. Patients with diabetes are more likely to be visually impaired than those who do not have the disease.
Pregabalin is safe and effective for the management of neuropathic pain associated with diabetic peripheral neuropathy. Drawbacks include the cost and the lack of studies demonstrating equivalence or superiority to other treatments. However, pregabalin’s ease of dosing titration, minimal drug intera...
Tight control of blood glucose levels and risk factors for cardiovascular disease (e.g., hypertension, hypercholesterolemia) can substantially reduce the incidence of microvascular and macrovascular complications from type 1 diabetes. Physicians play an important role in helping patients make essent...
Sep 1, 2006 Issue
ADA Releases Standards of Medical Care for Patients with Diabetes [Practice Guidelines]
The American Diabetes Association (ADA) has published a position statement containing evidence-based recommendations for diabetes care, treatment goals, and tools to evaluate the quality of care.
Aug 15, 2006 Issue
CDC Reports on End-stage Renal Disease in Patients with Diabetes [Practice Guidelines]
The Centers for Disease Control and Prevention (CDC) has released a report detailing the incidence of end-stage renal disease (ESRD) in patients with diabetes. Diabetes mellitus is the leading cause of ESRD in the United States, accounting for 44 percent of new cases in 2002.
Insulin detemir is suitable as basal insulin in a basal-bolus regimen. In limited research, it has been shown to cause slightly fewer episodes of minor hypoglycemia and no weight gain in patients with type 1 and 2 diabetes, which is a benefit that must be balanced against its higher price. Insulin d...
Jul 1, 2006 Issue
Antihypertensive Agents for Prevention of Diabetic Nephropathy [Cochrane for Clinicians]
Angiotensin-converting enzyme (ACE) inhibitors are the only antihypertensive agents with proven effectiveness for the primary prevention of diabetic nephropathy (defined as an albumin excretion of less than 30 mg per day on three serial measurements) caused by type 1 or type 2 diabetes. However, ACE...
Jun 15, 2006 Issue
Few Americans with Diabetes Receive Multiple Preventive-Care Services [Practice Guidelines]
Preventive-care services such as annual foot and dilated eye examinations and biannual A1C tests can prevent or delay amputation and blindness from diabetes. The Centers for Disease Control and Prevention (CDC) analyzed data from the Behavioral Risk Factor Surveillance System surveys to determine th...